Cargando…
Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer’s disease
Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disease, characterized by hyperphosphorylated tau, found in individuals with a history of exposure to repetitive head impacts. While the neuropathologic hallmark of CTE is found in the cortex, hippocampal tau has proven to be...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114683/ https://www.ncbi.nlm.nih.gov/pubmed/33980303 http://dx.doi.org/10.1186/s40478-021-01189-4 |
_version_ | 1783691100615081984 |
---|---|
author | Cherry, Jonathan D. Esnault, Camille D. Baucom, Zachary H. Tripodis, Yorghos Huber, Bertrand R. Alvarez, Victor E. Stein, Thor D. Dickson, Dennis W. McKee, Ann C. |
author_facet | Cherry, Jonathan D. Esnault, Camille D. Baucom, Zachary H. Tripodis, Yorghos Huber, Bertrand R. Alvarez, Victor E. Stein, Thor D. Dickson, Dennis W. McKee, Ann C. |
author_sort | Cherry, Jonathan D. |
collection | PubMed |
description | Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disease, characterized by hyperphosphorylated tau, found in individuals with a history of exposure to repetitive head impacts. While the neuropathologic hallmark of CTE is found in the cortex, hippocampal tau has proven to be an important neuropathologic feature to examine the extent of disease severity. However, the hippocampus is also heavily affected in many other tauopathies, such as Alzheimer’s disease (AD). How CTE and AD differentially affect the hippocampus is unclear. Using immunofluorescent analysis, a detailed histologic characterization of 3R and 4R tau isoforms and their differential accumulation in the temporal cortex in CTE and AD was performed. CTE and AD were both observed to contain mixed 3R and 4R tau isoforms, with 4R predominating in mild disease and 3R increasing proportionally as pathological severity increased. CTE demonstrated high levels of tau in hippocampal subfields CA2 and CA3 compared to CA1. There were also low levels of tau in the subiculum compared to CA1 in CTE. In contrast, AD had higher levels of tau in CA1 and subiculum compared to CA2/3. Direct comparison of the tau burden between AD and CTE demonstrated that CTE had higher tau densities in CA4 and CA2/3, while AD had elevated tau in the subiculum. Amyloid beta pathology did not contribute to tau isoform levels. Finally, it was demonstrated that higher levels of 3R tau correlated to more severe extracellular tau (ghost tangles) pathology. These findings suggest that mixed 3R/4R tauopathies begin as 4R predominant then transition to 3R predominant as pathological severity increases and ghost tangles develop. Overall, this work demonstrates that the relative deposition of tau isoforms among hippocampal subfields can aid in differential diagnosis of AD and CTE, and might help improve specificity of biomarkers for in vivo diagnosis. |
format | Online Article Text |
id | pubmed-8114683 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81146832021-05-12 Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer’s disease Cherry, Jonathan D. Esnault, Camille D. Baucom, Zachary H. Tripodis, Yorghos Huber, Bertrand R. Alvarez, Victor E. Stein, Thor D. Dickson, Dennis W. McKee, Ann C. Acta Neuropathol Commun Research Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disease, characterized by hyperphosphorylated tau, found in individuals with a history of exposure to repetitive head impacts. While the neuropathologic hallmark of CTE is found in the cortex, hippocampal tau has proven to be an important neuropathologic feature to examine the extent of disease severity. However, the hippocampus is also heavily affected in many other tauopathies, such as Alzheimer’s disease (AD). How CTE and AD differentially affect the hippocampus is unclear. Using immunofluorescent analysis, a detailed histologic characterization of 3R and 4R tau isoforms and their differential accumulation in the temporal cortex in CTE and AD was performed. CTE and AD were both observed to contain mixed 3R and 4R tau isoforms, with 4R predominating in mild disease and 3R increasing proportionally as pathological severity increased. CTE demonstrated high levels of tau in hippocampal subfields CA2 and CA3 compared to CA1. There were also low levels of tau in the subiculum compared to CA1 in CTE. In contrast, AD had higher levels of tau in CA1 and subiculum compared to CA2/3. Direct comparison of the tau burden between AD and CTE demonstrated that CTE had higher tau densities in CA4 and CA2/3, while AD had elevated tau in the subiculum. Amyloid beta pathology did not contribute to tau isoform levels. Finally, it was demonstrated that higher levels of 3R tau correlated to more severe extracellular tau (ghost tangles) pathology. These findings suggest that mixed 3R/4R tauopathies begin as 4R predominant then transition to 3R predominant as pathological severity increases and ghost tangles develop. Overall, this work demonstrates that the relative deposition of tau isoforms among hippocampal subfields can aid in differential diagnosis of AD and CTE, and might help improve specificity of biomarkers for in vivo diagnosis. BioMed Central 2021-05-12 /pmc/articles/PMC8114683/ /pubmed/33980303 http://dx.doi.org/10.1186/s40478-021-01189-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Cherry, Jonathan D. Esnault, Camille D. Baucom, Zachary H. Tripodis, Yorghos Huber, Bertrand R. Alvarez, Victor E. Stein, Thor D. Dickson, Dennis W. McKee, Ann C. Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer’s disease |
title | Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer’s disease |
title_full | Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer’s disease |
title_fullStr | Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer’s disease |
title_full_unstemmed | Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer’s disease |
title_short | Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer’s disease |
title_sort | tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and alzheimer’s disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114683/ https://www.ncbi.nlm.nih.gov/pubmed/33980303 http://dx.doi.org/10.1186/s40478-021-01189-4 |
work_keys_str_mv | AT cherryjonathand tauisoformsaredifferentiallyexpressedacrossthehippocampusinchronictraumaticencephalopathyandalzheimersdisease AT esnaultcamilled tauisoformsaredifferentiallyexpressedacrossthehippocampusinchronictraumaticencephalopathyandalzheimersdisease AT baucomzacharyh tauisoformsaredifferentiallyexpressedacrossthehippocampusinchronictraumaticencephalopathyandalzheimersdisease AT tripodisyorghos tauisoformsaredifferentiallyexpressedacrossthehippocampusinchronictraumaticencephalopathyandalzheimersdisease AT huberbertrandr tauisoformsaredifferentiallyexpressedacrossthehippocampusinchronictraumaticencephalopathyandalzheimersdisease AT alvarezvictore tauisoformsaredifferentiallyexpressedacrossthehippocampusinchronictraumaticencephalopathyandalzheimersdisease AT steinthord tauisoformsaredifferentiallyexpressedacrossthehippocampusinchronictraumaticencephalopathyandalzheimersdisease AT dicksondennisw tauisoformsaredifferentiallyexpressedacrossthehippocampusinchronictraumaticencephalopathyandalzheimersdisease AT mckeeannc tauisoformsaredifferentiallyexpressedacrossthehippocampusinchronictraumaticencephalopathyandalzheimersdisease |